Thiazole Compounds for Mitochondrial Protection in Degenerative Diseases
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for degenerative diseases associated with mitochondrial damage and dysfunction, such as retinitis pigmentosa, Alzheimer's, and Parkinson's, are limited in efficacy and safety, with existing metabolic cofactors like Coenzyme Q, nicotinamide, riboflavin, carnitine, biotin, and lipoic acid providing occasional benefits but lacking general utility in clinical practice.
Innovation Solution
Development of compounds according to formula (I), specifically designed to protect against calcium- and oxidative-stress mediated damage to mitochondrial function, which are administered to treat degenerative diseases and disorders, including retinal degenerative diseases, by mitigating mitochondrial damage and preserving respiratory capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing metabolic cofactors (Coenzyme Q, nicotinamide, riboflavin, carnitine, biotin, lipoic acid) are used for treatment, then occasional benefits are provided, but general utility and efficacy are limited
Solution Approach 1:
The patent modifies the chemical structure of existing metabolic cofactors by introducing specific substituents at defined positions, creating compounds with enhanced mitochondrial protective activity while maintaining their metabolic function, thereby improving both efficacy and general utility
Solution Approach 2:
The invention combines multiple functional groups (pyridinyl, phenyl, alkoxy, amino substituents) into a composite molecular structure that integrates the benefits of different cofactor types, creating a multi-functional compound with broader therapeutic applicability
2Reliability
If mitochondrial function is protected against calcium- and oxidative-stress mediated damage, then cell death is prevented, but the complexity of the compound structure increases
Solution Approach 1:
The compound is divided into distinct functional segments: a core structure (formula I) with specific substitutable positions (R1-R6), allowing systematic optimization of protective function while maintaining structural organization and facilitating medicinal chemistry development
Data Source
AI summary
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degenerative diseases and disorders.